As current and future growth in the drug discovery and development arena focuses on biologics, the accomplished Developmental and Reproductive Toxicology (DART) team at MPI Research is ready to meet the study needs of its sponsors. Unlike small molecules, which are active in many species, biologics are species specific and, in most cases, nonhuman primates are the only appropriate choice for preclinical testing.